ARTICLE | Company News
Sigma-Tau S.p.A., Solvay deal
February 9, 2009 8:00 AM UTC
Sigma-Tau acquired Solvay's Chenix chenodeoxycholic acid tablets for an undisclosed sum. Sigma-Tau plans to develop the compound to treat cerebrotendinous xanthomatosis (CTX) disease, a metabolic di...